Immunome向美国FDA提交Varegacestat新药申请 用于成人硬纤维瘤治疗

美股速递
Apr 29

Immunome Inc. (IMNM) 宣布已正式向美国食品药品监督管理局提交Varegacestat的新药申请,该药物旨在治疗成人硬纤维瘤患者。此次申报标志着公司在肿瘤治疗领域取得重要进展。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10